Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Conditions
Interventions
Intervention1: VCOR GOLD
(Co Enzyme Q10, L- Arginine, L- Carnitine, Lycopene, Omega 3 Fatty Acids providing Eicosapentaenoic Acid, Docosahexaenoic Acid, Natural Mixed Carotenoids, Wheat Germ Oil, Calc
Sponsors
Dr Smruti Shephalika Dey
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with OSMF clinically Stage II ( Pindborg s classification, 1989) 2) Who have already quit gutkha/arecanut chewing habit or have effectively quit after counseling. 3) Not received any treatment for OSMF in the past. 4) Age between 25 years to 55 years of any gender.
Exclusion criteria
Exclusion criteria: 1) Patient with any systemic disorder like hypertension, diabetes mellitus, respiratory, cardiovascular or renal disorder. 2) Patient having other oral mucosal disease, pericoronal infections and temporomandibular joint dysfunctions. 3) Pregnant or breast-feeding women. 4) Other adverse habits such as alcohol use, smoking, vaping, or e-cigarette use with or without gutkha chewing. 5) Patients not willing to be a part of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Change or improvement in maximal interincisal distance & severity in burning sensation. 2) Post- treatment discomfort or pain as a result of the intervention. Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Oral health quality of life assessed by validated questionnaire. (Tadakamadla et al., 2017) 2) Complete clinical resolution of the lesion and remission. Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Abhishek Ranjan Pati
Institute of Dental Sciences, Bhubaneswar
Outcome results
None listed